Technology

Taking Control of Germs in the Palm of Your Hand with UVCeed

 
 
Dr. Peter Bonutti, M.D., the Co-founder & CEO of UVCeed, a smart UVC disinfection system to help limit the spread of infections, particularly COVID-19 joins eHealth Radio and the COVID-19 Information and Disinfection Channels. Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience.
Listen to interview with host Eric Michaels and guest Dr. Peter Bonutti discuss the following:
As an MD why did you see the need to create a UV disinfection solution for consumers?
What is the problem you are solving? What is the science behind UVCeed? How does it work?
What are some of the most common uses for the product?
UVCeed eliminates 99.9 of the germs including Covid-19. Does this eliminate the need for face masks and sanitizers now?
Where can our audience get the app and the device today?
Dr. Peter Bonutti, M.D. is co-founder & CEO of UVCeed. He created the smart UVC disinfection system to help limit the spread of infections, particularly COVID-19.
Dr. Bonutti is a surgeon, inventor, author, professor, consultant, and entrepreneur with over 30 years of experience. He is the founder of Bonutti Research, a medical device incubator that has developed products and technology used around the world, including UVCeed, and maintains his clinical and surgical practice, focusing on adult knee and hip arthroplasty and integration of robotics into surgical procedures.
Dr. Bonutti is a pioneer in Minimally Invasive Surgery, has over 500 patents and applications, more than 700 licenses and multiple FDA-approved products to date. Major corporations leveraging his technology include Hitachi, Medtronic, Kyphon, Covidien, US Surgical, Biomet, Arthrocare, Synthes, Zimmer/Biomet and Stryker. He is a prolific speaker, lecturing internationally, and has trained over 100 surgeons on his surgical techniques.
In his career, Dr. Bonutti has received more than a dozen industry honors and awards for his achievements. Dr. Bonutti earned his medical degree at University of Cincinnati College of Medicine and completed his Orthopaedic Surgery Residency at Cleveland Clinic Foundation with international fellowships in Canada, Australia, and Austria.
 
 
Website: https://uvceed.com 
Social Media Links: Instagram: https://instagram.com/uvceedsanitizer  Linkedin: https://linkedin.com/company/bonutti-technologies/about 
 

Dr. Martin M. Grajower, discusses innovations to help both physicians and patients fight the silent epidemic of fatty liver disease

 
 
Dr. Martin M. Grajower, M.D., FACP, FACE, a Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine, Bronx, New York, joins eHealth Radio and the Health News and Technology Channels to discuss innovations to help both physicians and patients fight the silent epidemic of fatty liver disease.
Listen to interview with host Eric Michaels and guest Dr. Martin M. Grajower discuss the following:
What are the main risk factors for nonalcoholic fatty liver disease (NAFLD)?
Can you explain the role that obesity plays in connection with NAFLD and diabetes?
What are the health risks associated with having NAFLD?
At what point should endocrinologists screen for NAFLD in patients with Type 2 diabetes?
Can you provide an example of how endocrinologists can help their patients who are at risk for liver disease?
Martin Grajower MD FACP FACE is an endocrinologist in the Bronx, New York, and is affiliated with Montefiore Medical Center and Columbia University Hospital of Physicians and Surgeons. He received his medical degree from Albert Einstein College of Medicine and has been in private practice for over 40 years. He holds the title of Clinical Professor of Medicine, Division of Endocrinology, at Albert Einstein College of Medicine.
 
About Echosens
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
 
 
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

Former Hernia Surgeon, Dr. Freedman, turned patient advocate shares advice for avoiding mesh and no mesh misconceptions

 
 
Dr. Bruce Freedman, Vice President of Clinical Development at TELA Bio, a medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in hernia repairs joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest Dr. Bruce Freedman discuss the following:
What are the current challenges with hernia repairs?
What are the most common concerns patients have about their hernia repair?
What is the difference between mesh and no mesh hernia repair?
What are the questions patients should be asking their doctors about hernia repair?
Where can patients go to learn more about their hernia repair treatment options?
Bruce Freedman, M.D., FACS is the Vice President of Clinical Development at TELA Bio. After 32 years as a private practice general surgeon specializing in hernia repair and abdominal wall reconstruction, Dr. Freedman joined TELA Bio in 2021 to advocate for a more natural hernia repair mesh option as an alternative to permanent and resorbable synthetic mesh. In his role, Dr. Freedman utilizes his extensive experience as a healthcare provider to share the clinical and financial benefits of the OviTex Reinforced Tissue Matrix portfolio with surgeons and hospital administration.
Websites: https://TELABio.com | https://abouthernia.com 
Social Media Links: Facebook: https://facebook.com/telabioinc  Instagram: https://instagram.com/telabio LinkedIn: https://linkedin.com/company/tela-bio Twitter: https://twitter.com/TELABioInc 

Educating Physicians and Patients on the Silent Epidemic of Fatty Liver Disease

 
 
Dr. Darryn Richard Potosky, MD, a Board Certified Gastroenterologist and Hepatologist joins eHealth Radio and the Health News and Technology Channels to discuss innovations to help both physicians and patients fight the silent epidemic of fatty liver disease.
Listen to interview with host Eric Michaels and guest Dr. Darryn Richard Potosky discuss the following:
What is the prevalence of fatty liver disease, and who should be monitored?
Fatty liver disease is often referred to as a “silent killer” -- What can patients do if they are potentially at risk without realizing?
What innovations or lifestyle changes do you see helping to reverse the liver disease epidemic?
What is the importance of routine monitoring for liver diseases? When and how often should physicians monitor a patients liver?
What can patients do to prevent or reverse liver diseases, and to keep their livers healthy?
Darryn Potosky, MD is a board certified gastroenterologist and hepatologist and is an Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at the University of Maryland School of Medicine in Baltimore, Maryland. He also serves as the current Director of Hepatology.
Dr. Potosky received his undergraduate degree from the University of Maryland College Park and his medical degree from the University of Maryland School of Medicine in Baltimore, Maryland. He completed his postgraduate training in internal medicine at the University of Maryland and Baltimore VA Medical Centers, where he was chosen as chief resident. He performed his gastroenterology and hepatology fellowship also at the University of Maryland and Baltimore VA Medical Centers. In addition, Dr. Potosky has completed a one year fellowship at the University of Maryland in transplant hepatology, focusing on the care of patients in and around the time of liver transplantation./p>
About Echosens
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

Mobile Health: Creating Healthy Cultures

 
 
John Halloran, the CEO and Founder at Mobile Health, the digital health and wellbeing solution that makes it simple to create healthy cultures joins eHealth Radio and the Health News and Technology Channels.
Listen to interview with host Eric Michaels and guest John Halloran discuss the following:
Can you tell the audience about your background and how you become an entrepreneur?
What is Mobile Health and how is it improving the quality of life for employees?
How did you build a successful customer base? 3) What are your greatest fears as an entrepreneur, and how do you manage them?
How has covid changed the mentality of both employers and their managers/directors?
Where can people get in touch with mobile Health and your services?
John Halloran is CEO and Founder at Mobile Health, the digital health and wellbeing solution that makes it simple to create healthy cultures. Prior to starting Mobile Health, Halloran was the CEO and founder of Worldwide Compensation, Inc. (WWC), which was twice lauded by industry researchers at Gartner as the Best-in-Class Provider of a Global Compensation Planning solution.
Website: https://mobilehealthconsumer.com 
Social Media Links: Facebook: https://facebook.com/mobilehealthmhc Linkedin: https://linkedin.com/company/mobile-health-consumer-inc- Twitter: https://twitter.com/MobileHealthMHC 

How Telehealth is Enhancing Patient Care and Health Outcomes

 
 
Michael Gorton, the CEO and founder of Recuro Health and Founding CEO and Chairman of Teladoc joins eHealth Radio and the Healthcare and Health News Channels. Recuro Health is an integrated digital health solution that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health outcomes approach.
Listen to interview with host Eric Michaels and guest Michael Gorton discuss the following:
How did Recuro start?
Tell us more about what Recuro offers as a digital health solutions company?
What makes Recuro different from other digital health companies?
Who are your services available to?
What role will digital health play post-pandemic as patients return to in-person doctor’s appointments?
Can you tell our viewers more about your Covid at-home lab testing kits?
How does digital health enhance healthcare in rural and underserved communities?
Can you speak more on Recuro’s approach to behavioral and mental health? What kind of digital health solutions does Recuro offer?
A quintessential entrepreneur, mentor, and company builder, Michael leads the Recuro Health team which includes several leaders from Teladoc, where he served as the founding CEO and pioneered an industry-changing health care model that created a new efficiency paradigm in healthcare by delivering physicians to patients nationwide in under 12 minutes for $35.
Gorton ran Teladoc as CEO and Chairman for the first seven years of operations. Under his term, the company grew from a concept to one of the most recognized innovations in healthcare, with nearly two million patient members nationwide. Under the Teladoc model, physicians made more and patients paid less. Teladoc was studied and advocated by most of the major healthcare think tanks and was recently named one of the most innovative companies in healthcare. Teladoc recently entered the NYSE and now has a market cap of over $30B.
Michael’s decades of experience as a strategic visionary, impacting the telecommunications, music and healthcare industries include a leadership role as a founder of Principal Solar where he applied his business expertise, scientific education and training to the renewable energy sector -- a strong voice and proponent of solar power.
He has served as a partner of the Texas Acceleration Group (TAG), an entity formed to assist startup companies and participated as a founder of Palo Duro Records. He is also credited as a founder of Internet Global, a company that delivered the first DSL network and one of the first VOIP networks. Prior to this, he worked as a project engineer at Dallas Power & Light dealing with power plants, distribution, transformer management and integration of renewable energy into the grid.
Michael earned a B.S. in engineering from Texas Tech, an M.S. in Physics from the University of Texas at Dallas and a Juris Doctorate from Texas A&M.
Website: https://www.recurohealth.com
Social Media Links: Facebook: https://facebook.com/RecuroHealthLinkedin: https://linkedin.com/company/recuro-healthTwitter: https://twitter.com/RecuroHealth

Thinking Nervous-System First with Garrett Salpeter

 
 
Garrett Salpeter, Founder and CEO of the NeuFit Method, a teachable care pathway around the Neubie® device that supports safe, consistent and optimal use of electrical stimulation joins eHealth Radio and the Health News & Technology Channels.
Listen to interview with host Eric Michaels and guest Garrett Salpeter discuss the following:
Give our listeners a brief definition of the nervous system. How does it work?
When might the nervous system impede recovery?
What is the NeuFit Method? How did you come up with it?
What is Neubie technology?
How can readers enhance recovery from physical trauma?
Garrett Salpeter combined training in neuroscience and engineering to start NeuFit, a company at the nexus of neurology and fitness, dedicated to treating athletes and patients in the realization of fitness goals, effective rehabilitation, and improved overall health. He is the host of The NeuFit Undercurrent, a podcast for patients and practitioners interested in learning more about neurology’s role in recovery and performance. Garrett and his team have worked with thousands of patients recovering from neurological impairments, chronic pain, and sports injuries, including professional athletes, sports teams, and universities.
 
 
Website: https://neu.fit
Social Media Links: LinkedIn: https://linkedin.com/in/garrett-salpeter Instagram: https://instagram.com/neufitrfp

The Future of Healthcare: LifeQ, the provider of biometrics and health information derived from wearable devices

 
 
Laurie Olivier, the Chief Executive Officer of LifeQ, the leading independent provider of biometrics and health information derived from wearable devices used in world leading health management solutions joins eHealth Radio and the Healthcare and Technology Channels.
Listen to interview with host Eric Michaels and guest Laurie Olivier discuss the following:
You bring over three decades of global technology and business leadership as CEO and founder of LifeQ, and you have served on the boards of more than 50 startup, private and public companies around the world. Tell us about yourself, and how you founded LifeQ.
What is LifeQ’s mission, and what does it do that is currently not being done?
Tell us about the biggest pain points when it comes to the digital aspect of healthcare, as well as your outlook on health and wellness technology.
How is LifeQ sequencing its coverages of the cardiovascular, respiratory, sleep, fitness, mental, musculoskeletal, renal and other areas?
How do you foresee LifeQ fitting into the future of healthcare and the overall health and wellness of people who use it?
Laurie Olivier is the Chief Executive Officer of LifeQ, the leading independent provider of biometrics and health information derived from wearable devices used in world leading health management solutions. Mr. Olivier leads the firm’s growth and overall vision, including investment, strategy and partnerships with global leaders in wearables, silicon manufacturers, digital platforms, and insurance companies — leading the movement toward improving health and wellness around the world.
Mr. Olivier brings over three decades of global technology and business leadership, thirty years of venture capital and private equity experience, and has served on the boards of more than 50 startup, private and public companies around the world, including the largest industrial conglomerate in South Africa. As the Atlanta-based partner of 4Di Capital, the South African based early-stage venture capital management firm, and the US-based partner of Veritas Venture Partners, a pioneering seed stage Israeli VC firm, Mr. Olivier is passionate about developing new technologies into startups that positively impact people and society.
Founded in 2014, LifeQ has two key value propositions: enable wearable devices to provide business and near clinical-grade health information streams; and generate health and wellness solutions for consumer, business and clinical applications.
Mr. Olivier earned his Bachelor of Science in Electronics Engineering from the University of Pretoria; a Bachelor of Commerce in Finance and Strategic Marketing; and a Diploma in Datametrics and Operational Research from the University of South Africa. Mr. Olivier’s work has been recognized by Dow Jones Venture Reporter, the Atlanta Journal Constitution, and the American Israel Chamber of Commerce. A native of Groot Marico, South Africa, Mr. Olivier lives in Atlanta with his wife.
Website: https://lifeq.com 
Social Media Links: LinkedIn: https://linkedin.com/company/lifeq  Facebook: https://facebook.com/lifeqinc Instagram: https://instagram.com/lifeqinc  Twitter: https://twitter.com/lifeqinc 

Céline Fournier, PhD, Chief Medical Officer, Echosens Discusses the Clinical Evidence and Future of Liver Screening Technology

 
 
Céline Fournier, PhD, the Chief Medical Officer of Echosens, a high-technology company offering the FibroScan family of products, joins eHealth Radio and the Health News and Technology Channels to discuss the robust clinical data FibroScan has and Echosens plan to continue building clinical evidence.
Listen to interview with host Eric Michaels and guest Dr. Céline Fournier discuss the following:
Could you tell us about the robust level of evidence FibroScan has and how many communications and guidelines recommend the value of FibroScan?
What is Echosens plan to continue building clinical evidence?
How might existing research on FibroScan impact NAFLD/NASH drug development?
If you were to look into the future when the drugs for fibrotic NASH become available, how do you see FibroScan best supporting clinical practice for managing patients on treatment?
Could you tell us about the clinical data strategy Echosens has in place and what long term goals you anticipate?
Céline Fournier, PhD, age 45, is presently Chief Medical Officer of Echosens (Paris, France). She graduated from University of Technology of Compiègne Engineering School (France) in Bioengineering in 1998. During the course of her engineering training, she studied one year at the University of Pennsylvania (Philadelphia, USA). She then went to the Laboratory of Parametric Imaging (Paris, France) to work on skin tissue characterization by ultrasound and defended her PhD in Bioengineering in 2002. She joined Echosens a few months later as Medical Affairs Manager to conduct the first multicenter clinical trial to validate the diagnosis performances of FibroScan. In 2012, she became Medical and Regulatory Affairs Director. As CMO since 2017, she is globally responsible for Clinical Operation, Medical Affairs as well as Clinical Application and Training.
About Echosens
Echosens, the developer of FibroScan®, is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases. FibroScan is supported by over 2,500 peer-reviewed publications and examinations are covered by Medicare, Medicaid and many insurance plans.
Website: https://echosens.com
Social Media Links: Facebook: facebook.com/fibroscan.echosens  Linkedin: linkedin.com/company/echosens  Youtube: youtube.com/user/EchosensTV Twitter: twitter.com/Echosens

How Digital Technology is Changing the Landscape of Elder Health Care

 
 
Avanlee Christine, the CEO and Founder of Avanlee Care, a new app that improves how families communicate and manage their care receiver’s health in real time joins eHealth Radio and the Senior Care and Technology Channels.
Listen to interview with host Eric Michaels and guest Avanlee Christine discuss the following:
Tell me about the Avanlee Elderly Care APP and how it is different than what is currently on the market?
What is the most important feature of the Avanlee Care APP?
What are the challenges of caring for an aging parent or relative?
How has digital technology improved elder care and what does the future hold in your opinion?
What does the future hold for senior care in America?
Avanlee Christine is a founder, technologist and businesswoman. Throughout her career Avanlee has worked to provide better health and social care solutions for the elderly. Her experience caring for others and working with her own family to care for her ailing grandfather for 8 years, led her to realize that there was no technology solution available on the market that helped families and care-givers effectively support the health and social needs of an aging relative remotely. With the pandemic that need became all the more acute. She founded Avanlee Care to address that gap and provide families with a solution to transform the quality of remote health and social care for their elderly relatives.
 
 
Website: AvanleeCare.com 
Social Media Links: Facebook: facebook.com/AvanleeCare Instagram: instagram.com/avanlee_careTwitter: twitter.com/avanleec